Vimarsana
Biggest News Aggregation in the World

Structural Heart Interventions News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structural Heart Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structural Heart Interventions Today - Breaking & Trending Today

Know signs of stroke? Quick action saved Houston man's life - Vimarsana News

Know signs of stroke? Quick action saved Houston man's life

UTHealth's Houston Mobile Stroke unit is an ambulance prepared specifically to respond to the medical emergency caused by a stroke, a stoppage of blood flow to

A Heart-to- Heart With Dr. Azeem Latib - Vimarsana News

A Heart-to- Heart With Dr. Azeem Latib

THE NEW Montefiore Structural Heart Program at White Plains Hospital provides patients with the most advanced procedures for heart valve.

Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at TCT23 - Vimarsana News

Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at TCT23

Supira's technology features a novel low profile, high continuous flow design that aims to provide full hemodynamic support for high-risk percutaneous coronary interventions (HRPCI) and cardiogenic shock (CS) patients with a single device

Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at the Upcoming TCT 2023 Conference - Vimarsana News

Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at the Upcoming TCT 2023 Conference

/PRNewswire/ -- Supira Medical, Inc., a Shifamed portfolio company, announced today that the company's percutaneous ventricular assist device (pVAD) will be...

Anteris Technologies completes DurAVRTM Early Feasibility Study enrolment - Vimarsana News

Anteris Technologies completes DurAVRTM Early Feasibility Study enrolment

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has successfully completed enrolment for its Early Feasibility Study (EFS), approved by the US Food and Drug...